BackOncology Institute(The) - Warrants (15/11/2026) Overview
Oncology Institute Inc (The) - Warrants (15/11/2026)

Oncology Institute(The) - Warrants (15/11/2026) Return on Equity

Valuation check: TOIIW's ROE is 145.67%, above the sector sector average of -5.87%.

Get informed when a big investor buys or sells

+ Follow

ROE

145.67%

Return on Equity

145.67%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Oncology Institute(The) - Warrants (15/11/2026) (TOIIW) FAQ

The latest ROE for TOIIW is 145.67%. That is above the sector sector average of -5.87%. Investors often review this figure alongside Oncology Institute(The) - Warrants (15/11/2026)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, TOIIW currently prints 145.67% for ROE, while the sector average sits near -5.87%. That is roughly 2582.3% above the sector mean. Large gaps often invite a closer look at Oncology Institute(The) - Warrants (15/11/2026)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Oncology Institute(The) - Warrants (15/11/2026) converts resources into returns. At 145.67%, TOIIW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting TOIIW's ROE (145.67%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.